Argatroban Injection, Solution
Product Images NDC 55150-241
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Argatroban (NDC 55150-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Relationship At Steady State Between Argatroban Dose, Plasma Argatroban Concentration And Anticoagulant Effect (Argatroban Fig1)
Figure 2. Inr Relationship Of Argatroban Plus Warfarin Versus Warfarin Alone (Argatroban Fig2)
Figure 3. Time-to-first Event For The Composite Efficacy Endpoint: Hit Patients Study 1 (Argatroban Fig3)
Figure 4. Time-to-first Event For The Composite Efficacy Endpoint: Hitts Patients Study 1 (Argatroban Fig4)
Package Label-principal Display Panel (50 mg per 50 mL (1 mg / mL))
Package Label-principal Display Panel (50 mg per 50 mL (1 mg / mL))
Package Label-principal Display Panel (50 mg per 50 mL (1 mg / mL) – Container-Carton (10 Vials))
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.